Market TradesPurchasesSalesCluster BuysBig Buys $500k+ See all views → Custom filter →

Ticker page

KLRA Insider Trading Activity

Track Kailera Therapeutics, Inc. (KLRA) insider transactions, SEC Form 4 filings, insider buys, insider sales, filing dates, trade values, and source links. Recent summary: 27 trades, 5 buys, and 0 sales. Learn more

Feed status Last SEC check:Loading Last Filing: Loading
View KLRA
Access Free feed
Quick read What does this view show?

What this shows

Market trades first

This view focuses on purchases and sales with reported trade value. Lower-signal rows are moved out of the first screen, not hidden.

Why it matters

Use it as the default scan

Start here when you want the newest activity that most retail investors expect from an insider trading feed.

How to read it

Open the full ledger when needed

Use All Form 4 Filings when you want grants, exercises, gifts, conversions, and every normalized row.

Filings

KLRA Form 4 filing history

Recent insider trading rows for this issuer. The SEC filing is the source record.

Status Loading

Loading public insider data...

Latest visible filing loading.

Public Form 4 filings, normalized for cleaner scanning.

TickerType & RoleValueFiled
Free weekly recapGet the easiest version of the insider feed in your inbox.
Get free recap

Latest news

KLRA headlines

Plain-English summary

KLRA insider activity summary

Kailera Therapeutics, Inc. (KLRA) insider activity over the recent reporting window includes 5 insider purchases totaling approximately $326.8M. Market data shows a current price of $24.26 and a market capitalization of $3.14B. Blue Collar Picks normalizes public SEC Form 4 filings into a research-friendly view organized by ticker, insider role, transaction type, filing date, and reported value. KLRA pages are designed as a research starting point, not investment advice. Verify the original SEC filing, read the transaction code, compare the trade against the insider's role and history, and consider whether the activity is an open-market purchase, a sale, a grant, an option exercise, or another lower-signal filing type before drawing conclusions.

Company snapshot

Kailera Therapeutics, Inc. at a glance

Market Cap$3.14B
SectorHealthcare
IndustryBiotechnology
P/E (TTM)—
Forward P/E—
Beta—
Dividend YieldNone
Shares Out129,537,314

Primary source

Verify with the original SEC filings

Blue Collar Picks normalizes public Form 4 records but the SEC filing is the source of record. Use the original filing before making any investment decision.

Open KLRA Form 4 filings on SEC EDGAR → See insider trading stocks ranked by activity → Read the Blue Collar Picks methodology → Read the investment disclaimer →

Weekly recap

Get the easier version in your inbox.

Start with the free weekly recap. Upgrade later if you want the paid daily brief.

Free weekly recap. No login required. Unsubscribe any time.

Method

Public data, presented plainly

Which view should I use?

Named views

Ready-made views give you a clear starting point before you touch filters.

Cluster logic

Cluster buys mean multiple insiders buying the same ticker inside a short window.

Normalized rows

Rows preserve filing date, trade date, role, value, and source links where available.

All data remains available

Filtered rows are not hidden. Grants, exercises, tax withholding, gifts, and conversions stay available in All Form 4 Filings, ticker history, and specialized views.